Emily Frances Calderwood

Title: Emily Frances Calderwood: Innovator in Pharmaceutical Chemistry

Introduction

Emily Frances Calderwood is a prominent inventor based in Framingham, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 3 patents to her name, her work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

One of her latest patents is focused on ATG7 inhibitors and the uses thereof. This patent discloses chemical entities that are compounds of a specific formula, which can be useful as inhibitors of ATG7. The patent also includes pharmaceutical compositions comprising these chemical entities and methods for using them in cancer treatment. Another notable patent involves bicyclic compounds with kinase inhibitory activity. This invention provides novel bicyclic compounds that serve as inhibitors of protein kinases, along with pharmaceutical compositions and methods for treating various diseases.

Career Highlights

Emily is currently associated with Millennium Pharmaceuticals Limited, where she continues to advance her research and development efforts. Her work is characterized by a strong focus on innovative solutions in the pharmaceutical industry.

Collaborations

Emily has collaborated with notable colleagues, including Alexandra E Gould and Paul D Greenspan, contributing to a dynamic research environment that fosters innovation.

Conclusion

Emily Frances Calderwood's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her patents reflect a commitment to developing effective treatments for serious medical conditions.